|Group 1||FDA regulated research: investigational drugs, devices, and biologics. This learner group must also complete the Good Clinical Practice module.|
|Group 2||Non-FDA regulated research: prevention/intervention studies, community-based studies, investigator-initiated studies that do not involve the use of investigational drugs, devices, or biologics. This learner group may also require completion of the Good Clinical Practice module.|
|Group 3||Human derived materials research: specimens, human tissue, genetic/reproductive material, medical records, databanks, and registries. This learner group may also require completion of the Good Clinical Practice module.|
|Group 7||Social and behavioral research: surveys, questionnaires, interviews, photography, tape recordings. This learner group may also require completion of the Good Clinical Practice module.|
|GCP||Good Clinical Practice|
*For any questions regarding CITI, please contact our Training Coordinator at 706-721-9630.
**If an investigator identifies a research team member who has requested accommodations for completing CITI modules, the investigator or the research team member should contact the AU IRB Office at (706) 721 -3110. The IRB Training Coordinator will work with the research team member to complete CITI under the needed, documented accommodations. The investigator should not be involved in applying the accommodations needed. (This includes but is not limited to entering answers for the individual, giving answers to the individual, taking the CITI modules for the individual, etc.) If you have any questions regarding accommodations, please contact the IRB Office at (706) 721-3110.